Transjugular Intrahepatic Portosystemic Shunt Linked to Increased Risk of Hepatocellular Carcinoma:A VA Matched Cohort Study

作     者：Shalini Bansal Tamar Taddei Rebecca Wells Marina Serper Theresa Bittermann Nadim Mahmud David E.Kaplan 

作者机构：Sidney Kimmel Medical College at Thomas Jefferson UniversityPhiladelphiaPAUSA Division of Gastroenterology and Hepatology Perelman School of MedicineUniversity of PennsylvaniaPhiladelphiaPAUSA Corporal Michael J.Crescenz VA Medical CenterPhiladelphiaPAUSA Division of Gastroenterology and HepatologyYale University School of MedicineNew HavenCTUSA VA Connecticut Healthcare SystemWest HavenCTUSA 

出 版 物：《Journal of Clinical and Translational Hepatology》 (临床与转化肝病杂志（英文版）)

年 卷 期：2024年第12卷第5期

页      面：534-538页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主　　题：Carcinoma invasion cirrhosis 

摘      要：Hepatocellular carcinoma(HCC)is the most common primary tumor of the liver and often evolves from regenerating nodules in liver *** there have been significant advances in the treatment of HCC,the overall prognosis in patients with a large tumor burden,vascular invasion,or extrahepatic spread remains poor.1 The magnitude of liver stiffness in cirrhosis has been consistently associated with an increased risk of development of HCC.